Long-term efficacy and tolerability of octreotide treatment in acromegaly
- 30 September 1992
- journal article
- clinical trial
- Published by Elsevier in Metabolism
- Vol. 41 (9) , 44-50
- https://doi.org/10.1016/0026-0495(92)90030-e
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- SMS 201-995 and Thyroid Function in Acromegaly:Hormone and Metabolic Research, 1992
- Therapeutic Efficacy of the Somatostatin Analog SMS 201-995 (Octreotide) in AcromegalyAnnals of Internal Medicine, 1990
- A Microassay for 1,25-Dihydroxyvitamin D Not requiring High Performance Liquid Chromatography: Application to Clinical Studies*Journal of Clinical Endocrinology & Metabolism, 1984
- Somatostatin and the 24 h levels of serum TSH, T3, T4, and reverse T3 in normals, diabetics and patients treated for myxoedemaActa Endocrinologica, 1980
- Twenty-four-hour somatostatin infusions in normals, juvenile diabetics, and maturity-onset diabeticsMetabolism, 1978
- Radioimmunological determination of reverse triiodothyronine in unextracted serum and serum dialysatesScandinavian Journal of Clinical and Laboratory Investigation, 1977
- Ultrasensitive Radioimmunoassay for Direct Determination of Free Triiodothyronine Concentration in SerumScandinavian Journal of Clinical and Laboratory Investigation, 1975
- The Inhibition by Somatostatin of the Thyrotropin Response to Thyrotropin-Releasing Hormone in Normal SubjectsScandinavian Journal of Clinical and Laboratory Investigation, 1974
- INHIBITION OF INSULIN SECRETION BY SOMATOSTATINThe Lancet, 1973
- Wick Chromatography for Rapid and Reliable Immunoassay of Insulin, Glucagon and Growth HormoneNature, 1968